Skip to Main Content

Paper Details

Healthcare resource utilization in patients receiving idarucizumab for reversal of dabigatran anticoagulation due to major bleeding, urgent surgery, or procedural interventions: interim results from the RE-VERSE ADâ¿¢ study.
J Med Econ
6
2017
Author NameAffiliation
Charles V Pollacka Thomas Jefferson University
Jerrold H Levyh Duke University Medical Center
  • 1 - 2

Datasets

Release 1.2